DERRIK ABELL: Open Payments
NPI 1821618471 · ANNA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 47 payments from 16 companies in 2025. Trend: 2023 $221 · 2024 $540 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $108 |
| Insulet Corporation | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $99 |
| Lilly USA, LLC | 7 | $95 |
| Medtronic, Inc. | 4 | $93 |
| Radius Health, Inc. | 3 | $86 |
| Tandem Diabetes Care, Inc. | 3 | $69 |
| Averitas Pharma Inc. | 2 | $50 |
| Amgen Inc. | 3 | $48 |
| Abbott Laboratories | 2 | $47 |
Products named: Omnipod, JARDIANCE, MOUNJARO, Tymlos, t:slim X2 Insulin Pump with Control-IQ, Rybelsus, QUTENZA, REPATHA.
Industry payments across IL — which companies pay providers there.
